Prevalence and impact of additional CHIP mutations in JAK2V617F ‐positive ischaemic cerebrovascular patients
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20242 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Marie Hvelplund Kristiansen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Ischemic Stroke, Janus Kinase 2, Ubiquitin-Protein Ligases, Retinal Artery Occlusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonden til Lægevidenskabens Fremme, Fabrikant Einar Willumsens Mindelegat, Harboefonden.
Abstract (Originalsprache)
The JAK2V617F mutation is associated with increased cardiovascular risk, including ischaemic stroke. This study investigates the prevalence of additional mutations in ischaemic cerebrovascular patients with and without JAK2V617F to better understand the mechanisms contributing to thrombotic risk. We examined 63 patients with the JAK2V617F mutation and 126 matched controls from a cohort of 591 ischaemic cerebrovascular patients. Somatic mutations were assessed using targeted next‐generation sequencing (NGS). Serum thromboinflammatory markers were evaluated in a subset of patients. Additional somatic mutations were more common in JAK2V617F ‐positive patients than in controls (47.6% vs. 30.2%, p = 0.028). Patients with JAK2V617F had a higher prevalence of other mutations with variant allele frequencies (VAFs) above 10% (23.8% vs. 7.9%, p = 0.005), a pattern that persisted in cases with JAK2V617F
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
- Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
- Section for Oral Biology and Immunopathology, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, Denmark.
ORCID-Profile: Marie Hvelplund Kristiansen, Vibe Skov, Morten Kranker Larsen, Lasse Kjær, Hans Carl Hasselbalch
Förderung
- Fonden til Lægevidenskabens Fremme
- Fabrikant Einar Willumsens Mindelegat
- Harboefonden
- Greater Copenhagen Health Science Partners
- Region Sjællands Sundhedsvidenskabelige Forskningsfond
- Toyota-Fonden
- Grosserer A.V. Lykfeldt og Hustrus Legat
- Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond
Zitieren
APA
Kristiansen, M. H., Skov, V., Larsen, M. K., Kjær, L., Nielsen, C. H., Hasselbalch, H. C., & Wienecke, T. (2025). Prevalence and impact of additional CHIP mutations in JAK2V617F ‐positive ischaemic cerebrovascular patients. British Journal of Haematology. https://doi.org/10.1111/bjh.20242
Vancouver
Kristiansen MH, Skov V, Larsen MK, Kjær L, Nielsen CH, Hasselbalch HC, et al. Prevalence and impact of additional CHIP mutations in JAK2V617F ‐positive ischaemic cerebrovascular patients. British Journal of Haematology. 2025. doi:10.1111/bjh.20242
BibTeX
@article{Kristiansen2025,
author = {Kristiansen, Marie Hvelplund and Skov, Vibe and Larsen, Morten Kranker and Kjær, Lasse and Nielsen, Claus Henrik and Hasselbalch, Hans Carl and Wienecke, Troels},
title = {Prevalence and impact of additional CHIP mutations in JAK2V617F ‐positive ischaemic cerebrovascular patients},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20242}
}
EUVIMED